US biotech ImmunityBio (Nasdaq: IBRX) has secured $75 million through a direct offering with a single institutional investor, ...

DelveInsight's Merkel Cell Carcinoma Market Insights report includes a comprehensive understanding of current treatment ...

It’s a biotech environment without many good choices. Even before President Donald Trump’s tariff announcement pushed stock ...

We recently published a list of 10 Stocks Under $10 that Will Triple. In this article, we are going to take a look at where ...

We recently published a list of Tuesday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where ...

ImmunityBio, Inc. (NASDAQ: IBRX) has announced the execution of a $75 million equity financing with a single institutional ...

In this article, we will discuss the 10 Stocks under $10 that will triple.

ImmunityBio (IBRX) announced that it has executed financing to provide further working capital and support its ongoing business operations. The ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has executed financing to provide ...

ImmunityBio, Inc.’s IBRX share price has dipped by 6.07%, which has investors questioning if this is right time to buy.

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced details about its Investor Day program to ...

Khanna’s Democratic colleague in the House, Rep. Lloyd Doggett of Texas, said the impacts of Trump’s tariff and austerity ...